Ustekinumab leads to high 6-week clinical response and 44-week remission ratesNovember 16, 2016Gastroenterology
Empirical micafungin falls short for treating suspected fungal infection in the ICUNovember 16, 2016Infectious DiseasesCritical Care
Treatment withdrawal without prior liver biopsy found safe in well-controlled autoimmune hepatitisNovember 16, 2016HepatologyGastroenterology
Hypervirulent Mycobacterium clone infecting cystic fibrosis patients worldwideNovember 16, 2016PulmonologyInfectious Diseases
Interatrial shunt benefits sustained for 1 year in HFpEF patientsNovember 16, 2016CardiologyPulmonology
Medicaid restrictions loosening on access to HCV therapiesNovember 16, 2016HepatologyGastroenterologyBusiness of Medicine
